
WHO Includes GLP-1 Weight Loss and Diabetes Drugs in Essential Medicines List
The WHO has added GLP-1 drugs for diabetes to its essential medicines list to improve global access, highlighting their importance despite high costs, and encouraging generic production to increase affordability. The list also includes treatments for cystic fibrosis and cancer, aiming to enhance availability worldwide.


